Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20161
20171
20181
20191
20211
20222
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Terumo Europe N.V.2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Bayer1
Boston Scientific Corporation1
Cambridge University Hospitals NHS Foundation Trust1
Erasmus Medical Center1
Hoffmann-La Roche1
Leiden University Medical Center1
Maastricht University Medical Center1
Mark C Burgmans, MD PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular13
Fibrosis3
Liver Neoplasms3
Diabetes Mellitus, Type 22
Neoplasm Metastasis2
Non-alcoholic Fatty Liver Disease2
Atherosclerosis1
Bone Neoplasms1
Burkitt Lymphoma1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.